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ABSTRACT
Objective: This survey provides an overview of the
development of policies and strategies for quality
improvement in European healthcare systems, by map-
ping quality improvement policies and strategies, progress
in their implementation, and early indications of their
impact.
Study design: A survey of quality improvement policies
and strategies in healthcare systems of the European
Union was conducted in 2005 for the first phase of the
Methods of Assessing Response to Quality Improvement
Strategies (MARQuIS) project.
Participants: The survey, completed by 68 key experts in
quality improvement from 24 European Union member
states, represents their views and accounts of quality
improvement policies and strategies in their healthcare
systems.
Principal findings: There are substantial international
and intra-national variations in the development of
healthcare quality improvement. Legal requirements for
quality improvement strategies are an important driver of
progress, along with the activities of national govern-
ments and professional associations and societies. Patient
and service user organisations appear to have less
influence on quality improvement. Wide variation in
voluntary and mandatory coverage of quality improvement
policies and strategies across sectors can potentially lead
to varying levels of progress in implementation. Many
healthcare organisations lack basic infrastructure for
quality improvement.
Conclusions: Some convergence can be observed in
policies on quality improvement in healthcare.
Nevertheless, the growth of patient mobility across
borders, along with the implications of free market
provisions for the organisation and funding of healthcare
systems in European Union member states, require
policies for cooperation and learning transfer.
The free movement of goods, services, finance and
people within the European Union (EU) has
profound implications for healthcare financing
and healthcare systems in the 27 member states.
1
The health policies of individual European member
states are becoming more interconnected and
interdependent, particularly because of the move-
ment of patients and health professionals across
national borders. However, each member state still
has primary responsibility within its own borders
for healthcare funding, and the provision and
monitoring of healthcare services, and the EU has
quite limited powers to act in this area.
2 The
growing internationalisation of healthcare systems
in Europe has an important bearing on the quality
and safety of health services.
3 While many member
states have enacted legislation and adopted policies
and strategies at a national level, little is known
about the relative progress, compatibility, and
likely interactions of these national policies and
strategies, or their likely implications for EU
initiatives.
4–7
We conducted a survey of quality improvement
(QI) policies and strategies in European healthcare
systems as part of the Methods of Assessing
Response to Quality Improvement Strategies
(MARQuIS) project.
8 The study set out to map
and describe the policies and strategies in use across
the EU, progress made in their implementation,
and early indications of their impact. Our aim was
to provide a basis for learning and exchange among
member states, and to inform future more detailed
empirical studies within MARQuIS at an organisa-
tional or hospital level.
METHODS
A literature review was conducted drawing on
comparative empirical research, commentaries and
theoretical papers, and national or international
reports and guidelines on quality in healthcare in
Europe, published over a 10-year period (1994–
2004).
9 We searched Medline, ASSIA, HMIC and
other databases, using as search terms, various
combinations of ‘‘quality’’, ‘‘health services’’,
‘‘health care’’ and ‘‘Europe’’. This literature was
used to develop an analytic framework and
questionnaire covering six main areas: national
environment and context, quality policy goals and
values, resources and support, policy implementa-
tion, information reporting and evaluation, and
impact. For the purposes of this survey ‘‘quality
improvement policies and strategies’’ was an
umbrella term used to cover a broad range of
quality assurance, quality control and quality
management approaches to improving healthcare
services. We made efforts to define these and other
terms used in the questionnaire clearly, but
recognised that the meaning and interpretation
attached to them by respondents could vary.
We used our own and others’ contacts and
networks, the membership of the International
Society for Quality in Health Care (ISQua), and
web resources to identify key experts in QI in all 25
member states of the EU, including members of
international quality societies and well-established
contacts in the field. They came from a range of
healthcare backgrounds including academia and
research, quality societies, policy making, quality
consultancies, healthcare management and clinical
practice. We approached 174 potential experts in
QI by email with information about the survey, of
whom 103 agreed to complete the questionnaire;
68 completed questionnaires were returned. The
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limited those experts who were able to take part. Quality
experts from 24 member states participated in the survey, and
the numbers of respondents were as follows: Austria (3),
Belgium (3) Cyprus (1), Czech Republic (2), Denmark (3),
Estonia (6), Finland (2), France (3), Germany (2), Greece (1),
Hungary (2), Ireland (2), Italy (5), Lithuania (2), Luxembourg
(2), Malta (2), the Netherlands (2), Poland (3), Portugal (3),
Slovakia (4), Slovenia (3), Spain (4), Sweden (3) and the UK.(5)
The survey took place between June and November 2005.
Quantitative data were analysed using SPSS v.10, to produce
a range of descriptive and inferential statistics. Qualitative data
were subjected to thematic and categorical analysis. For
quantitative data, we considered aggregating responses from
each country and presenting them at the national level, rather
than simply analysing and presenting data for Europe as a
whole. However, the numbers of respondents in some
individual countries were too small to permit reliable analysis,
and we found that in about half of the countries there were
important variations in health policies and health systems at a
subnational (provincial, state or county) level which made
national level analyses potentially misleading. Our full report
presents some analyses at both levels.
10 In this paper, we mainly
present the descriptive results from the survey for Europe as a
whole, while using some country-level data where it was
appropriate to do so, by way of example.
RESULTS
National environment and context
The most important drivers for the development of policies and
strategies for healthcare quality by governments were reported
as being the work of professional organisations—for example:
medical and scientific societies; the policies and priorities of
current governments; and media coverage of quality issues in
healthcare. Less influence was attributed to patient and service
user organisations, and to international drivers such as the
policies and initiatives of the European Commission, and the
activities of ISQua (table 1).
Quality improvement policies and strategies in member states
can be developed at national governmental level or at a regional
level, or from the combined, coordinated or distinctive efforts of
national and regional governments. Forty-four per cent of
respondents reported the development of quality policies
primarily at the national level, 46% at combined national and
regional levels, and 10% primarily at the regional level. Table 2
offers some examples of each.
Fifty-five per cent of respondents reported that there was a
great deal or a moderate amount of variation in policies across
regions in their country. Some key regional differences were
reported in:
c approaches to measuring and evaluating quality;
c priorities across regions and between national and regional
levels;
c how national policies were interpreted or implemented at
regional level;
c organisation and implementation of QI;
c access to resources to support QI;
c professional motivation, training, and competence.
Quality policy goals and values
Seventy-eight per cent of respondents reported that in their
country there was a statutory legal requirement for healthcare
organisations to have QI systems, and such a requirement was
in place in at least 18 of the 24 member states covered by our
survey. Most commonly (36%), respondents reported that this
requirement had been in place for between 5 and 10 years.
Hospital services and health services in the public sector
appeared to be the main focus of legal requirements in QI,
and they less commonly applied to long-term and primary care
and to the independent or private healthcare sector.
Respondents were invited to list what they saw as their
government’s three most important priorities for QI within
their own healthcare systems. The most important priorities
identified were:
c development of quality standards and guidelines (18
member states);
c improving patient safety, orientation, and involvement (16
member states);
c improving the assessment and evaluation of QI (9 member
states);
c improving information and reporting systems (8 member
states);
c achieving better value for money (6 member states).
Two-thirds of respondents (66%) reported that there was a
national policy document on QI in healthcare produced by
government. As table 3 shows, these national policy documents
frequently set out definitions of QI, systems for monitoring and
measuring QI, and targets for QI. Rather less frequently they
addressed issues such as the provision of training and support
for QI, or the resourcing of QI.
Table 1 The level of importance given to different influences on the development of quality improvement
policies and strategies (n=68 respondents)
Influences on the development of quality improvement
policies
Very
important
% (n)
Fairly
important
% (n)
Not very
important
% (n)
Not at all
important
% (n)
Don’t
know
% (n)
Professional organisations, medical and scientific societies 28 (19) 51 (35) 15 (10) 3 (2) 3 (2)
Policies and priorities of the current government 54 (37) 21 (14) 15 (10) 7 (5) 3 (2)
Media coverage of quality issues or problems in healthcare 25 (17) 44 (30) 25 (17) 3 (2) 3 (2)
National or regional quality task force or working group 35 (24) 32 (22) 19 (13) 10 (7) 3 (2)
Provider organisations, eg, hospitals or primary care providers 22 (15) 44 (30) 24 (16) 7 (5) 3 (2)
Public opinion about the quality of healthcare 19 (13) 44 (30) 25 (17) 7 (5) 4 (3)
Development of quality improvement policies in other EU
countries
21 (14) 38 (26) 29 (20) 9 (6) 3 (2)
Patient and service user organisations 7 (5) 43 (29) 40 (27) 7 (5) 3 (2)
Policies and initiatives of the European Commission 10 (7) 22 (15) 53 (36) 12 (8) 3 (2)
Activities of the International Society for Quality in Health Care 4 (3) 25 (17) 44 (30) 24 (16) 3 (2)
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It was noted earlier that respondents reported that most
countries had some statutory requirement for healthcare
providers to have systems of QI in place, particularly in the
public hospital sector. We identified the six most commonly
used QI systems in our literature search, and then asked
respondents to indicate whether they were mandatory (their
use was required) or voluntary (they could be used if the
organisation wanted to do so) in hospitals. As table 4 shows,
none of these QI systems was widely mandated in the hospital
sector, and there was a heavy reliance on voluntary participa-
tion and implementation. Patient satisfaction surveys and
performance indicator measures were reported as rather more
likely to be mandatory, while accreditation and organisational
quality or total quality management programmes were much
less so. The six most commonly used QI systems that we
identified in the literature were also used as a framework in
subsequent work packages for the MARQuIS project.
11
Respondents were also asked about the extent to which a
wide range of measures to support the implementation of QI
were present in hospitals in their country. As table 5 shows,
they tended to report that longstanding traditional QI systems
such as committees for infection control, arrangements for
equipment maintenance and laboratory quality control proce-
dures were well established. However, the fundamental
components of a QI programme, including an organised system
for undertaking QI projects, resources for QI activities, regular
QI reviews of departments, and training in QI methods were all
reported to be much less commonly found in hospitals.
Progress and impact
Respondents were invited to reflect and report on the three
most important achievements in QI in their healthcare system
within the past 3 years. The most frequently cited achieve-
ments in QI were:
c establishing national accreditation or quality assurance
systems (17 member states);
c establishing a national society for quality in healthcare (13
member states);
c extending patient choice, patient rights and patient safety
(13 member states);
c improving the training and assessment of professionals (12
member states).
These and the wide range of other achievements reported
tended to be concerned with the creation or development of
Table 2 Variation in the locus for development of quality
policies and strategies in government
National National and regional Regional
France Germany UK
Luxembourg The Netherlands Spain
Hungary Austria Italy
Sweden
Table 3 The content of national quality improvement (QI) policy documents (n= 45 respondents who
reported having access to a quality improvement policy document)
Topics in a policy document on quality improvement
Topic is
included
% (n)
Topic is not
included
% (n)
Don’t know
% (n)
Systems for monitoring and measuring progress of QI 82 (37) 13 (6) 4 (2)
Definition of terms, eg, what is meant by QI 78 (35) 18 (8) 4 (2)
Setting national targets for QI 73 (33) 27 (12) 0
Systems for asking patients and the public for their views on quality in
healthcare
73 (33) 24 (11) 2 (1)
Setting national standards for quality 71 (32) 27 (12) 2 (1)
Systems for dealing with adverse events, problems and complaints
from patients
62 (28) 36 (16) 2 (1)
Systems for professional regulation and monitoring professional
performance
56 (25) 42 (19) 2 (1)
Setting standards for professional education or training 53 (24) 38 (17) 9 (4)
Provision of training or support for healthcare organisations on QI 44 (20) 56 (25) 0
Provision of resources for QI 40 (18) 56 (25) 4 (2)
QI, quality improvement.
Table 4 The mandatory use of quality improvement policies and strategies in hospital services (n=68
respondents)
Quality improvement policy and strategy in hospitals
Required in
hospitals
% (n)
Voluntary in
hospitals
% (n)
Not
applicable/
Don’t know
% (n)
Systems for getting the views of patients, eg, satisfaction surveys,
monitoring complaints
50 (34) 43 (29) 7 (5)
Performance indicators or measures 47 (32) 46 (31) 7 (5)
Patient safety systems, eg, incident reporting, risk management 44 (30) 47 (32) 9 (6)
Clinical guidelines, practice guidelines 40 (27) 54 (37) 6 (4)
Accreditation schemes and programmes 27 (18) 54 (37) 19 (13)
Audit, internal assessment of clinical standards 25 (17) 63 (43) 12 (8)
Organisational quality management programmes, eg, total quality
management
22 (15) 66 (45) 12 (8)
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directly with the outcomes of improvement themselves.
Respondents were also asked to report on the main factors
which had acted either as facilitators or barriers to the progress
of healthcare QI; the results are summarised in table 6.
Respondents saw the key facilitators of progress as professional
involvement and training, the existence of a statutory legal
requirement for QI, and public demand or expectations, while
the main barriers were a lack of funding, poor political
leadership and strategic planning, and a lack of incentives or
motivations for healthcare organisations and professionals to
engage with QI.
DISCUSSION
National and international differences in quality improvement
Our survey suggests that there are substantial variations in the
development of healthcare QI across the EU, both internation-
ally and within some member states where policies and
strategies are formulated more at a regional than at a national
level. These variations make comparisons difficult, but also
create an opportunity for international learning and the
exchange of experiences and ideas. While there are some
countries in which healthcare QI has been a governmental
policy concern for up to 20 years or longer, in most it has
become a key concern for policy makers particularly in the past
5–10 years. But there are some countries within Europe where
the development of healthcare QI is still relatively new, or even
embryonic. In broad terms, these findings concur with those of
earlier and smaller international surveys in this area.
45
Legal frameworks for quality improvement
The existence of a statutory legal requirement to implement QI
strategies for healthcare systems and organisations was reported
as being perhaps the most important incentive for supporting
progress in the development of QI initiatives. The implementa-
tion and development of quality policies may therefore be at a
more advanced stage in member states which have such a legal
requirement, and which have had a legal requirement in place
for a substantial period of time. The minority of member states
who have not yet enacted legislation to require healthcare
Table 5 The coverage of measures to support the implementation of quality improvement (QI) policies and strategies in the hospital sector (n=68
respondents)
Measure of support
In all or most
hospitals
% (n)
In many
hospitals
% (n)
In some
hospitals
% (n)
In a few
hospitals
% (n)
In none
% (n)
Don’t
know
% (n)
Committee for infection control 57 (39) 25 (17) 13 (9) 1 (1) 0 3 (2)
Systems for QI in laboratories 38 (26) 38 (26) 12 (8) 4 (3) 0 7 (5)
Regular maintenance of clinical equipment 40 (27) 32 (22) 9 (6) 10 (7) 1 (1) 7 (5)
Committee for QI 21 (14) 31 (21) 18 (12) 24 (16) 3 (2) 4 (3)
Reporting systems for quality problems such as adverse incidents or events 28 (19) 18 (12) 19 (13) 25 (17) 6 (4) 4 (3)
Staff training in QI 9 (6) 32 (22) 35 (24) 19 (13) 0 4 (3)
Clear responsibilities for clinical performance 24 (16) 16 (11) 16 (11) 25 (17) 12 (8) 7 (5)
Director or leader of QI at a senior level in the organisation 7 (5) 28 (19) 24 (16) 34 (23) 4 (3) 3 (2)
A QI plan for the organisation 7 (5) 24 (16) 31 (21) 29 (20) 2 (1) 7 (5)
Information systems to provide data on quality of care 9 (6) 19 (13) 22 (15) 35 (24) 9 (6) 6 (4)
Regular staff performance reviews 13 (9) 13 (9) 24 (16) 35 (24) 7 (5) 7 (5)
Training for leadership in QI 4 (3) 21 (14) 38 (26) 22 (15) 9 (6) 6 (4)
Regular internal quality reviews of departments or parts of the organisation 6 (4) 18 (12) 37 (25) 28 (19) 7 (5) 4 (3)
An organised programme of QI projects 9 (6) 13 (9) 32 (22) 35 (24) 4 (3) 6 (4)
Systematic follow-up and re-auditing of QI projects 4 (3) 9 (6) 22 (15) 44 (30) 15 (10) 6 (4)
Dedicated finance or budget for QI 4 (3) 6 (4) 19 (13) 49 (33) 15 (10) 7 (5)
QI, quality improvement.
Table 6 Factors identified by respondents as facilitators or barriers to the progress of healthcare quality improvement (QI)
Facilitators Barriers
c Professional involvement, training, and initiatives (16 member states) c Under-funding (17 member states)
c A legal requirement to implement QI (15 member states) c Lack of political leadership and strategic planning (15 member states)
c Public demand, expectations and involvement (12 member states) c Lack of incentives, confused incentives, low motivation (12 member states)
c Quality improvement projects, eg, accreditation, licensing, awards, quality assurance,
circles and forums, quality committees, improvement centres (10 member states)
c Cultural barriers, eg, professional or bureaucratic (11 member states)
c Political interest (9 member states) c Lack of professional training or education (10 member states)
c Harmonisation of policy across the EU, progress in other member states, international
guidelines (7 member states)
c Under-staffing, time issues, neglect of staff interests (10 member states)
c A national strategy for QI (7 member states) c Inadequate management and governance structures (9 member states)
c A national society for quality (6 member states) c Lack of clarity in standards, accountability, controls, and priorities (5 member
states)
c Financial incentives to implement QI (6 member states) c Weak public pressure (5 member states)
c Strong leadership (5 member states) c Punitive and negative approaches to monitoring quality or errors (5 member
states)
c Data on clinical performance (5 member states) c Lack of coordination; networking at organisational, local, and regional levels (5
member states)
c Having clear and explicit QI policies (4 member states) c Political change and transition (4 member states)
c Lack of and fear of transparency (4 member states)
c Inadequate or uncoordinated data on quality (4 member states)
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place may wish to consider the experience of those member
states which have done so.
Who drives quality improvement
In this survey, national governments emerged as the key players
in developing QI policies, setting quality standards and targets,
and providing guidance and support to organisations on
implementation. This reflects the major role that national
governments play in healthcare funding and provision in
member states. However, it was notable that patient and
service user organisations were reported as having the least
influence on the development of QI policies. It might be argued
that the predominant influence of governments and of the
health professions through professional associations and socie-
ties means it is more difficult for patient and user groups to
have their voices heard, and to play their part in shaping QI
policies and strategies. This could mean that those policies and
strategies, and the QI activities they produce, reflect a
professional- and provider-based view of what constitutes
high-quality care.
Variable progress in policy implementation
Although most member states have some form of legal,
statutory requirement for QI in healthcare systems and
organisations, and most national governments have issued
policy documents which set out their policies and strategies, we
found that the extent to which specific QI systems or
approaches are required or mandated varies considerably, and
the existence of the basic infrastructure for QI at a hospital level
is rather less established than one might expect. The data
suggest wide variation in the voluntary and mandatory coverage
of different QI policies and strategies across sectors, potentially
leading to varying levels of progress and coverage in implemen-
tation. The basic infrastructure for a viable QI programme is
still not present in many healthcare organisations.
Impact
The survey provides some limited evidence of the early impact
of national quality policies and strategies, although those
achievements were often described by respondents in terms of
the development of capacity and capability for QI in healthcare
systems, rather than with direct examples or evidence of
improved quality. It appears that there are significant barriers to
progressing QI, particularly concerned with funding, leadership,
and incentives for both organisations and individuals. Overall,
the survey results suggest that healthcare QI has made at least
some progress in most countries of the EU, and that in some
states there are now quite comprehensive and robust quality
assessment and improvement mechanisms in place.
Limitations
Some limitations of our study have already been noted. The
small numbers of respondents overall, and their varying levels of
knowledge and experience about sometimes complex policies at
a national or subnational level, all suggest that caution should
be exercised in interpreting these results, and particularly in
making any country-level comparisons. However, later phases
of the MARQuIS project in which we undertook surveys at the
hospital level and conducted a programme of hospital visits
afforded some opportunities for verification through triangula-
tion, and broadly served to confirm and support these findings.
CONCLUSION
Policies on quality improvement in healthcare have largely
developed at a national level in EU member states, and have
been driven by largely national concerns. Nevertheless, we
observed some degree of policy convergence in areas such as the
widespread adoption of legal or statutory requirements for
healthcare organisations to put quality improvement systems in
place, the development of specific mechanisms such as accred-
itation programmes, and the recent policy priority accorded to
patient safety in many member states. However, it seems
unlikely that such natural convergence will produce coordinated
or integrated quality systems in healthcare at a European level,
unless the ends of coordination and integration are more
proactively pursued. The growth of cross-border healthcare, and
the implications of free market provisions for the organisation
and funding of healthcare systems in EU member states, both
create a need for some degree of cooperation at a policy level.
More practically, it is clear that many EU member states could
benefit by learning from the experience gained and progress
made in quality improvement policies and strategies by other
countries within Europe.
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